Kim, Jeri
Merck & Co., Inc., Rahway, NJ, USA (United States)
5 papers on CoChatORCID 0000-0001-6254-7755
Most cited papers
- Verified
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Study, T. P., Schumacher, F. R., (APCB), A. P. C. B., Study, T. I., Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, (CAPS), C. O. T. P. I. S., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, et al. (2018) · Nature Genetics
Genetic Associations and EpidemiologyProstate Cancer Treatment and Research
Cited by 902
- Verified
Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study
Antonarakis, E. S., Piulats, J. M., Gross-Goupil, M., Goh, J., Ojamaa, K., Hoimes, C. J., Vaishampayan, U., Berger, R., Sezer, A., Alanko, T., et al. (2020) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers
Cited by 736
- Verified
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
Vijayakrishnan, J., Studd, J., Broderick, P., Kinnersley, B., Holroyd, A., Law, P. J., Kumar, R., Allan, J. M., Harrison, C. J., Moorman, A. V., et al. (2018) · Nature Communications
Acute Lymphoblastic Leukemia researchGenetic Associations and Epidemiology
Cited by 84
- Verified
Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity
Salas, T. R., Kim, J., Vakar-Lopez, F., Sabichi, A. L., Troncoso, P., Jenster, G., Kikuchi, A., Chen, S.-Y., Shemshedini, L., Suraokar, M., et al. (2004) · Journal of Biological Chemistry
Prostate Cancer Treatment and ResearchWnt/β-catenin signaling in development and cancer
Cited by 81
- Verified
Pembrolizumab for metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: updated analysis of KEYNOTE-199
Antonarakis, E. S., Goh, J. C., Gross-Goupil, M., Vaishampayan, U. N., Piulats, J. M., De Wit, R., Alanko, T., Fukasawa, S., Tabata, K., Feyerabend, S., et al. (2019) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free